Cell Signaling Technology

NDRG1 (D8G9) Rabbit Monoclonal Antibody

#9485 · western blot · $161,384

64
Evidence Score · Well-Established
Used by 386 independent labs across 428 papers. How we score this →
100
Citing papers
3.6k
Combined citations
Supplier page Find this product

Research areas

RNA modifications and cancer7Genomics, phytochemicals, and oxidative stress6CRISPR and Genetic Engineering5Mitochondrial Function and Pathology5Cancer, Hypoxia, and Metabolism5Cancer Mechanisms and Therapy5Glutathione Transferases and Polymorphisms5Cancer Cells and Metastasis4

Papers citing this product

1
Mesenchymal stem cells deliver exogenous miR‐21 <i>via</i> exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration
Journal of Cellular and Molecular Medicine·2017·311 cit.·DOI
2
The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity
Journal of Neuroscience·2011·183 cit.·DOI
3
Rapamycin‐mediated <scp>mTORC</scp> 2 inhibition is determined by the relative expression of <scp>FK</scp> 506‐binding proteins
Aging Cell·2015·173 cit.·DOI
4
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate
Molecular Therapy — Methods & Clinical Development·2018·158 cit.·DOI
5
Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
Nature Cancer·2022·148 cit.·DOI
6
Methazolamide and Melatonin Inhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of Ischemic Injury
Stroke·2009·146 cit.·DOI
7
Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs
Nature Communications·2021·132 cit.·DOI
8
Inhibitors of Cytochrome<i>c</i>Release with Therapeutic Potential for Huntington's Disease
Journal of Neuroscience·2008·118 cit.·DOI
9
<i>N</i>-Acetyl-Serotonin Offers Neuroprotection through Inhibiting Mitochondrial Death Pathways and Autophagic Activation in Experimental Models of Ischemic Injury
Journal of Neuroscience·2014·112 cit.·DOI
10
A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer
Nature Communications·2024·101 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
NDRG1 AntibodyRabbitCell Signaling Technology64$317100
NDRG1 (D10F8) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology64$161,351100
NDRG1 (D6C2) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology64$161,351100
NDRG1 (E2T5I) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology64$161,35112
NDRG1 (D10F8) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology64$84311
NDRG1 (D8G9) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology64$8652

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.